Jeremy Grummet

Assoc Prof Jeremy Grummet is an Associate Professor in Surgery at Monash University and Director of Urology at Alfred Health. Specializing in prostate cancer diagnosis and treatment, he pioneered transperineal biopsy as a safer alternative to transrectal methods, now the Australian standard. Co-founder of MRI PRO, a global prostate MRI training program, he also chairs the EAU Prostate Cancer Guidelines Panel (non-European representative). His research focuses on diagnostic accuracy, biopsy-related sepsis, MRI-targeted biopsy, and focal brachytherapy. He supervises medical students and is Co-PI on the LIBERATE registry studying targeted prostate cancer treatments. His work contributes to UN SDG 3 (Good Health).

Education: MBBS, MS, FRACS (not explicitly listed but inferred from titles).

Research Interests: Prostate Cancer Diagnostics, Urology Innovations, Focal Therapy, Biopsy Techniques, Medical Imaging.

Key Contributions: TREXIT initiative (ending transrectal biopsy), MRI PRO program, clinical trials on pain reduction in biopsies (ANZUP 1501 trial), and leadership in global guidelines. Collaborations include PCOR-ANZ and international registries.

Awards/Grants: Not explicitly stated in text but implies grant-funded research via clinical registries and trials.

Labs/Teams: MRI PRO Training Program, LIBERATE Registry, Alfred Health Urology Team.